33698
document
Several indicators of oxidative stress , immunity , and illness improved in trained men consuming an encapsulated juice powder concentrate for 28 weeks . Phytonutrients from plant foods provide numerous antioxidants . We hypothesized that supplementation for 28 wk with a commercially available encapsulated juice powder concentrate ( JPC ) could influence indicators of oxidative stress , immunity , and illness . Trained men ( n = 41 ; 34 +/- 5 y ; maximum oxygen uptake = 55 +/- 7 mL x kg ( -1 ) x min ( -1 ) ) from a homogenous police Special Forces unit were randomly assigned in a double blind manner to either JPC ( n = 21 ) or placebo ( n = 20 ) . We used multiple 7-d food records to assess dietary intake and found inadequate mean daily fruit and vegetable consumption ( 3.2 +/- 1.2 servings ) . The group physician documented all duty days lost due to illness . We collected plasma at baseline and study wk 4 , 8 , 16 , and 28 for analysis of carbonyl groups on protein ( CP ) and TNFalpha . Over the 28-wk investigation , CP was lower in the JPC group , with both a treatment and a time x treatment interaction ( P < 0.05 ) . Concentrations of both CP and TNFalpha at 16 and 28 wk were lower in the JPC than in the placebo group ( P < 0.001 ) . TNFalpha increased during the first 8 wk followed by a decrease in both groups for the following 20 wk ( P < 0.001 ) . Over the final 20 wk of the study , the placebo group tended to have more days of illness than the JPC group ( P = 0.068 ) . These data suggest beneficial JPC effects with regard to reduction of duty days lost due to illness and reduction of CP and TNFalpha concentrations in this group of trained men over 28 wk .
33699
Intervention_Pharmacological
encapsulated juice powder concentrate
33700
Intervention_Pharmacological
Phytonutrients from plant foods
33701
Intervention_Pharmacological
commercially available encapsulated juice powder concentrate ( JPC )
33702
Intervention_Pharmacological
JPC
33703
Intervention_Control
or placebo
33704
Intervention_Pharmacological
JPC
33705
Intervention_Pharmacological
JPC
33706
Intervention_Control
placebo
33707
Intervention_Control
placebo
33708
Intervention_Pharmacological
JPC
33709
Intervention_Pharmacological
JPC
33710
Outcome_Other
indicators of oxidative stress , immunity , and illness
33711
Outcome_Other
oxidative stress
33712
Outcome_Other
immunity
33713
Outcome_Other
illness
33714
Outcome_Physical
illness
33715
Outcome_Other
carbonyl groups on
33716
Outcome_Physical
protein ( CP ) and TNFalpha
33717
Outcome_Physical
CP
33718
Outcome_Physical
CP
33719
Outcome_Physical
TNFalpha
33720
Outcome_Physical
TNFalpha
33721
Outcome_Physical
illness
33722
Outcome_Physical
illness
33723
Outcome_Physical
CP
33724
Outcome_Physical
TNFalpha concentrations